• Corpus ID: 9381789

Temporal release of growth factors from platelet-rich fibrin (PRF) and platelet-rich plasma (PRP) in the horse: a comparative in vitro analysis.

  title={Temporal release of growth factors from platelet-rich fibrin (PRF) and platelet-rich plasma (PRP) in the horse: a comparative in vitro analysis.},
  author={Jonathan McLellan and Sarah Plevin},
  journal={International Journal of Applied Research in Veterinary Medicine},
  • J. McLellan, S. Plevin
  • Published 2014
  • Medicine, Biology
  • International Journal of Applied Research in Veterinary Medicine
Objectives: To evaluate platelet-rich fibrin (PRF) in horses and compare temporal release of growth factors (GF) to platelet-rich 

Figures and Tables from this paper

The L-PRF Membrane (Fibrin Rich in Platelets and Leukocytes) and Its Derivatives (A-PRF, I-PRF) Are Useful as a Source of Stem Cells in Regenerative Wound Therapy: Experimental Work on the Horse
To ensure that tissue engineering methods are widely applicable in the clinical setting, it is necessary to modify them in such a way that they are readily available and relatively easy to use in daily clinical routine.
Production Protocol Standardisation, Macroscopic and Histological Evaluation, and Growth Factor Quantification of Canine Leukocyte-and Platelet-Rich Fibrin Membranes
The data confirm the effectiveness of this protocol and of Wound Box to produce L-PRF membranes in dogs and confirm a well-defined histoarchitecture with five layers reproducing density and distribution of blood cells in this biomaterial.
Does Double Centrifugation Lead to Premature Platelet Aggregation and Decreased TGF-β1 Concentrations in Equine Platelet-Rich Plasma?
Although the double-centrifugation protocol caused premature platelet aggregation, it seems to be an effective method for preparation of PRP with high platelet and TGF-β1 concentrations.
Fibrin Rich in Leukocyte-Platelets ( L-PRF ) and Injectable Fibrin Rich Platelets ( i-PRF ) , Two Opportunity in Regenerative Surgery : Review of The Sciences and Literature
This review article focuses on the development of various platelet concentrates, their fabrication procedure, advantages and disadvantages for use in regenerative surgery and healing process.
Platelet-Rich Products and Their Application to Osteoarthritis.
Selection of an Animal Model for the Production of Leukocyte-Fibrin Rich Platelet Membranes (L-PRF); Standardized Protocol Proposed for Clinical Use and the Use of L-PRF Wound Box®
The hypothesis is that the L-PRF is easy to produce in the horse, without modifications of the human protocol, thus allowing a better standardization of thehuman protocol.
L-PRF Membrane (Fibrin Rich in Platelets and Leukocytes) and Its Derivatives (A-PRF, i-PRF) are Helpful as a Basis of Stem Cells in Regenerative Injury Treatment: Trial Work on the Horse
The general objective of creating platelet concentrates of natural origin can be delivered near the patient to quicken the implantation procedure, being monetarily practical for the patient and the health framework.
Second-Generation Platelet Concentrates (PRFs): Estimation of Cellular Content
The study sought to standardize the PRF preparation procedure by validating a statistical system to calculate the exact amount of platelets and leukocytes in second-generation solid platelet concentrates, making it easy to evaluate individual PRF arrays on time in the clinical setting.


Slow release of growth factors and thrombospondin-1 in Choukroun's platelet-rich fibrin (PRF): a gold standard to achieve for all surgical platelet concentrates technologies
Choukroun's platelet-rich fibrin (PRF) is a second generation platelet concentrate that releases high quantities of three main growth factors, including TGFβ-1, platelet derived growth factor AB, PDGF-AB and an important coagulation matricellular glycoprotein during 7 days.
Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part IV: clinical effects on tissue healing.
  • J. ChoukrounA. Diss D. Dohan
  • Medicine, Biology
    Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics
  • 2006
Platelet-rich fibrin constructs elute higher concentrations of transforming growth factor-β1 and increase tendon cell proliferation over time when compared to blood clots: a comparative in vitro analysis.
Both PRFM constructs are comprised of a dense fibrin scaffold that contains increased concentrations of TGF-β1 and are capable of increasing tendon cell proliferation over time when compared with a BC.
Platelet Rich Plasma: Biology and New Technology
Fundamental background on platelet biology and the role of platelets in both hemostasis and wound healing, as well as methods of preparing, characterizing, and using platelet rich plasma are presented to provide the reader a foundation on which to critically evaluate prior studies and plan future work are presented.
Effects of platelet-derived growth factor-BB on the metabolic function and morphologic features of equine tendon in explant culture.
Results suggest that rhPDGF-BB use may be of benefit in the repair of equine tendon, particularly through induction of collagen type I mRNA.
Effects of activated platelet concentrates on human primary cultures of fibroblasts and osteoblasts.
There were no statistical differences in fibroblast proliferation, or in osteoblast growth and functions between serum-free conditions and the platelet gel treatment, therefore, neither fibro Blast proliferation nor osteoblasts growth and function were affected by the activated platelet concentrates in vitro.
Effects of platelet-rich plasma on the repair of wounds on the distal aspect of the forelimb in horses.
Platelet-rich plasma favored excessive development of granulation tissue and significantly slowed wound healing at 1, 2, and 3 weeks after surgery, which may better suit wounds with massive tissue loss or chronic wounds that would benefit from a fresh source of mediators to accelerate the healing process.
A proposed protocol for the standardized preparation of PRF membranes for clinical use.
Autologous platelet‐rich fibrin matrix as cell therapy in the healing of chronic lower‐extremity ulcers
From the results of this small‐scale pilot study, PRFM shows significant potential for closing of chronic leg ulcers, and patients with >50% reduction in wound area were allowed to continue to complete closure.